Peter Lakatos
Affiliations: | Clinical Medicine | Semmelweis Egyetem, Hungary |
Area:
Cell BiologyGoogle:
"Peter Lakatos"Children
Sign in to add traineeSimon Fischer | grad student | 2008 | Semmelweis Egyetem |
Andras Khoor | grad student | 2011 | Semmelweis Egyetem |
Lajos S. Kiss | grad student | 2011 | Semmelweis Egyetem |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Wetwittayakhlang P, Verdon C, Starr M, et al. (2023) Mucosal Healing and Clinical Efficacy of Adalimumab in Small Intestinal Crohn's Disease (SIMCHA Study): Final Results From a Prospective, Open-Label, Single-Arm Study. The Turkish Journal of Gastroenterology : the Official Journal of Turkish Society of Gastroenterology |
Wetwittayakhlang P, Gonczi L, Golovics PA, et al. (2023) Time Trends of Environmental and Socioeconomic Risk Factors in Patients with Inflammatory Bowel Disease over 40 Years: A Population-Based Inception Cohort 1977-2020. Journal of Clinical Medicine. 12 |
Kablawi D, Aljohani F, Palumbo CS, et al. (2023) Nonalcoholic Fatty Liver Disease Increases Cardiovascular Risk in Inflammatory Bowel Diseases. Crohn's & Colitis 360. 5: otad004 |
Kurti Z, Gonczi L, Lakatos L, et al. (2022) Epidemiology, treatment strategy, natural disease course and surgical outcomes of patients with ulcerative colitis in Western Hungary - a population-based study between 2007 and 2018, data from the Veszprem County cohort. Journal of Crohn's & Colitis |
Gonczi L, Lakatos L, Kurti Z, et al. (2022) Incidence, prevalence, disease course and treatment strategy of Crohn's disease patients from the Veszprem cohort, Western Hungary - a population-based inception cohort study between 2007 and 2018. Journal of Crohn's & Colitis |
Hahn GD, Golovics PA, Wetwittayakhlang P, et al. (2022) Is There a Best First Line Biological/Small Molecule in IBD: Are We Ready for Sequencing? Biomedicines. 10 |
Guillo L, Abreu M, Panaccione R, et al. (2022) Endpoints for extraintestinal manifestations in inflammatory bowel disease trials: the EXTRA consensus from the International Organization for the Study of Inflammatory Bowel Diseases. The Lancet. Gastroenterology & Hepatology |
Wetwittayakhlang P, Albader F, Golovics PA, et al. (2021) Clinical Outcomes of COVID-19 and Impact on Disease Course in Patients with Inflammatory Bowel Disease. Canadian Journal of Gastroenterology & Hepatology. 2021: 7591141 |
Al Khoury A, Balram B, Bessissow T, et al. (2021) Patient Perspectives and Expectations in Inflammatory Bowel Disease: A Systematic Review. Digestive Diseases and Sciences |
Zhao M, Gönczi L, Lakatos PL, et al. (2021) The burden of inflammatory bowel disease in Europe in 2020. Journal of Crohn's & Colitis |